Praxis Precision Medicines, Inc. Balance Sheet
PRAX / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Praxis Precision Medicines, Inc. had $938M in total assets and $878M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357.3M | $215.4M | $81.3M | $61.6M | $138.7M | $296.6M | $44.8M |
| Current Assets | $610.9M | $404.4M | $84.9M | $110.8M | $287.4M | $302.3M | $45.5M |
| PP&E (Net) | $147.0K | $230.0K | $588.0K | $971.0K | $1.2M | $82.0K | $128.0K |
| Total Assets | $937.9M | $483.1M | $87.9M | $115.1M | $292.7M | $303.2M | $47.7M |
| Current Liabilities | $59.8M | $37.5M | $15.7M | $34.3M | $38.4M | $15.7M | $6.8M |
| Shareholders' Equity | $878.1M | $445.4M | $69.7M | $76.1M | $250.8M | $287.5M | -$81.0M |